본문 바로가기
KERD
논문KCI 등재

Thrap3 promotes nonalcoholic fatty liver disease by suppressing AMPK-mediated autophagy

박성호|김홍태|최장현|채영찬|Ryu Dongryeol|Myung Kyungjae|Jo Yunju|Dao Tam|Jang Hyun-Jun|Lee Yo Han|Khim Keon Woo|Eom Hye-jin|Lee Ju Eun|Song Yi Jin|Choi Sun Sil|Park Kieun|Ji Haneul|Park Neung Hwa
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2023.12|Experimental and Molecular Medicine|제55권 |pp. 1720-1733|DOI 10.1038/s12276-023-01047-4

2

조회

0

다운로드

1

인용

0

참고문헌

주제분류생화학

초록

Autophagy functions in cellular quality control and metabolic regulation. Dysregulation of autophagy is one of the major pathogenic factors contributing to the progression of nonalcoholic fatty liver disease (NAFLD). Autophagy is involved in the breakdown of intracellular lipids and the maintenance of healthy mitochondria in NAFLD. However, the mechanisms underlying autophagy dysregulation in NAFLD remain unclear. Here, we demonstrate that the hepatic expression level of Thrap3 was significantly increased in NAFLD conditions. Liver-specific Thrap3 knockout improved lipid accumulation and metabolic properties in a high-fat diet (HFD)-induced NAFLD model. Furthermore, Thrap3 deficiency enhanced autophagy and mitochondrial function. Interestingly, Thrap3 knockout increased the cytosolic translocation of AMPK from the nucleus and enhanced its activation through physical interaction. The translocation of AMPK was regulated by direct binding with AMPK and the C-terminal domain of Thrap3. Our results indicate a role for Thrap3 in NAFLD progression and suggest that Thrap3 is a potential target for NAFLD treatment.

Abstract

Autophagy functions in cellular quality control and metabolic regulation. Dysregulation of autophagy is one of the major pathogenic factors contributing to the progression of nonalcoholic fatty liver disease (NAFLD). Autophagy is involved in the breakdown of intracellular lipids and the maintenance of healthy mitochondria in NAFLD. However, the mechanisms underlying autophagy dysregulation in NAFLD remain unclear. Here, we demonstrate that the hepatic expression level of Thrap3 was significantly increased in NAFLD conditions. Liver-specific Thrap3 knockout improved lipid accumulation and metabolic properties in a high-fat diet (HFD)-induced NAFLD model. Furthermore, Thrap3 deficiency enhanced autophagy and mitochondrial function. Interestingly, Thrap3 knockout increased the cytosolic translocation of AMPK from the nucleus and enhanced its activation through physical interaction. The translocation of AMPK was regulated by direct binding with AMPK and the C-terminal domain of Thrap3. Our results indicate a role for Thrap3 in NAFLD progression and suggest that Thrap3 is a potential target for NAFLD treatment.

참고문헌 (63)

  1. Loomba, R, "The global NAFLD epidemic", Nat. Rev. Gastroenterol. Hepatol, 10, pp.686~690 (2013)
  2. Wree, A., "From NAFLD to NASH to cirrhosis-new insights into disease mechanisms", Nat. Rev. Gastroenterol. Hepatol, 10, pp.627~636 (2013)
  3. Postic, C., "Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance : lessons from genetically engineered mice", J. Clin. Invest, 118, pp.829~838 (2008)
  4. Byrnes, K., "Therapeutic regulation of autophagy in hepatic metabolism", Acta. Pharm. Sin B, 12, pp.33~49 (2022)
  5. Lin, C. W., "Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice", J. Hepatol, 58, pp.993~999 (2013)
  6. Grefhorst, A., "The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease", Front. Endocrinol, 11, pp.601627~ (2020)
  7. Lahiri, V., "Watch What You(Self-)Eat : Autophagic Mechanisms that Modulate Metabolism", Cell Metab, 29, pp.803~826 (2019)
  8. Smith, B. K., "Treatment of nonalcoholic fatty liver disease : role of AMPK", Am. J. Physiol. Endocrinol. Metab, 311, pp.E730~E740 (2016)
  9. Choi, J. H., "Thrap3 docks on phosphoserine 273 of PPARgamma and controls diabetic gene programming", Genes Dev, 28, pp.2361~2369 (2014)
  10. Lee, Y. H., "Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA", Elife, 10 (2021)[DOI]
  11. Kabeya, Y., "LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing", EMBO J, 19, pp.5720~5728 (2000)
  12. Aran, D., "Comprehensive analysis of normal adjacent to tumor transcriptomes", Nat. Commun, 8, pp.1077~ (2017)
  13. Pihlajamaki, J., "Thyroid hormone-related regulation of gene expression in human fatty liver", J. Clin. Endocrinol. Metab, 94, pp.3521~3529 (2009)
  14. Hoang, S. A., "Gene Expression Predicts Histological Severity and Reveals Distinct Molecular Profiles of Nonalcoholic Fatty Liver Disease", Sci. Rep, 9, pp.12541~ (2019)
  15. Govaere, O., "Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis", Sci. Transl. Med, 12 (2020)[DOI]
  16. Pfister, D., "NASH limits anti-tumour surveillance in immunotherapy-treated HCC", Nature, 592, pp.450~456 (2021)
  17. Moon, J. S., "Growth differentiation factor 15 protects against the agingmediated systemic inflammatory response in humans and mice", Aging Cell, 19, pp.e13195~ (2020)
  18. Jang, H. J., "Glucosylceramide synthase regulates adipo-osteogenic differentiation through synergistic activation of PPARgamma with GlcCer", FASEB J, 34, pp.1270~1287 (2020)
  19. Brunt, E. M., "Nonalcoholic fatty liver disease(NAFLD)activity score and the histopathologic diagnosis in NAFLD : distinct clinicopathologic meanings", Hepatology, 53, pp.810~820 (2011)
  20. Lam, J., "A Universal Approach to Analyzing Transmission Electron Microscopy with ImageJ", Cells, 10 (2021)[DOI]
  21. Postic, C., "DNA excision in liver by an albumin-Cre transgene occurs progressively with age", Genesis, 26, pp.149~150 (2000)
  22. Czaja, M. J., "Function of Autophagy in Nonalcoholic Fatty Liver Disease", Dig. Dis. Sci, 61, pp.1304~1313 (2016)
  23. Tanaka, S., "Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice", Hepatology, 64, pp.1994~2014 (2016)
  24. He, A., "Acetyl-CoA Derived from Hepatic Peroxisomal beta-Oxidation Inhibits Autophagy and Promotes Steatosis via mTORC1 Activation", Mol. Cell, 79, pp.30~42 (2020)
  25. Challa, T. D., "Liver ASK1 protects from non-alcoholic fatty liver disease and fibrosis", EMBO Mol. Med, 11, pp.e10124~ (2019)
  26. Mauvezin, C., "Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A", SERCA-dependent autophagosome-lysosome fusion, 2015, pp.11, 1437~1438
  27. Sunny, N. E., "Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease : Novel Mechanisms and Treatment Strategies", Trends Endocrinol. Metab, 28, pp.250~260 (2017)
  28. Chen, Q., "High-Fat Diet-Induced Mitochondrial Dysfunction Promotes Genioglossus Injury-A Potential Mechanism for Obstructive Sleep Apnea with Obesity", Nat. Sci. Sleep, 13, pp.2203~2219 (2021)
  29. Ma, X., "Role and Mechanisms of Mitophagy in Liver Diseases", Cells, 9 (2020)[DOI]
  30. Kang Hyun Je, "Thrap3 promotes R-loop resolution via interaction with methylated DDX5", Experimental and Molecular Medicine, 53, pp.1~10 (2021), 생화학분자생물학회[DOI]
  31. Lee, K. M., "TRAP150 activates pre-mRNA splicing and promotes nuclear mRNA degradation", Nucl. Acids Res, 38, pp.3340~3350 (2010)
  32. Vohhodina, J., "The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export", Nucl. Acids Res, 45, pp.12816~12833 (2017)
  33. Afinanisa, Q., "AMPK Localization: A Key to Differential Energy Regulation", Int. J. Mol. Sci, 22 (2021)[DOI]
  34. Kodiha, M., "Localization of AMP kinase is regulated by stress, cell density, and signaling through the MEK–>ERK1", 2 pathway, 2007, pp.293, C1427~C1436
  35. Wang, Z., "Inhibition of a Novel CLK1-THRAP3-PPARgamma Axis Improves Insulin Sensitivity", Front. Physiol, 12, pp.699578~ (2021)
  36. Kim, J., "AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1", Nat. Cell Biol, 13, pp.132~141 (2011)
  37. Nwadike, C., "AMPK Inhibits ULK1-Dependent Autophagosome Formation and Lysosomal Acidification via Distinct Mechanisms", Mol. Cell Biol, 38 (2018)[DOI]
  38. Melser, S., "Mitochondrial degradation and energy metabolism", Biochim. Biophys. Acta, 1853, pp.2812~2821 (2015)
  39. Nadal-Casellas, A., "Long-term high-fat-diet feeding impairs mitochondrial biogenesis in liver of male and female rats", Cell Physiol. Biochem, 26, pp.291~302 (2010)
  40. Rub, C., "Mitochondrial quality control by the Pink1", Parkin system, 2017, pp.367, 111~123
  41. Gehrke, S., "PINK1 and Parkin control localized translation of respiratory chain component mRNAs on mitochondria outer membrane", Cell Metab, 21, pp.95~108 (2015)
  42. Jacoupy, M., "The PINK1 kinase-driven ubiquitin ligase Parkin promotes mitochondrial protein import through the presequence pathway in living cells", Sci. Rep, 9, pp.11829~ (2019)
  43. Ge, P., "PINK1 and Parkin mitochondrial quality control : a source of regional vulnerability in Parkinson’s disease", Mol. Neurodegener, 15, pp.20~ (2020)
  44. Hung, C. M., "AMPK", ULK1-mediated phosphorylation of Parkin ACT domain mediates an early step in mitophagy, 2021, pp.7, ~
  45. Melser, S., "Rheb regulates mitophagy induced by mitochondrial energetic status", Cell Metab, 17, pp.719~730 (2013)
  46. Carling, D., "Beyond energy homeostasis : the expanding role of AMPactivated protein kinase in regulating metabolism", Cell Metab, 21, pp.799~804 (2015)
  47. Hardie, D. G., "AMPK : positive and negative regulation, and its role in whole-body energy homeostasis", Curr. Opin. Cell Biol, 33, pp.1~7 (2015)
  48. Warden, S. M., "Post-translational modifications of the beta-1 subunit of AMPactivated protein kinase affect enzyme activity and cellular localization", Biochem. J, 354, pp.275~283 (2001)
  49. Suzuki, A., "Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase", Mol. Cell Biol, 27, pp.4317~4327 (2007)
  50. Rodriguez-Vargas, J. M., "Autophagy requires poly(adp-ribosyl)ation-dependent AMPK nuclear export", Cell Death Differ, 23, pp.2007~2018 (2016)
  51. Fukuo, Y., "Abnormality of autophagic function and cathepsin expression in the liver from patients with non-alcoholic fatty liver disease", Hepatol. Res, 44, pp.1026~1036 (2014)
  52. Czaja, M. J., "Functions of autophagy in hepatic and pancreatic physiology and disease", Gastroenterology, 140, pp.1895~1908 (2011)
  53. Koga, H., "Altered lipid content inhibits autophagic vesicular fusion", FASEB J, 24, pp.3052~3065 (2010)
  54. Jin Lee, "Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease", Archives of Pharmacal Research, 42(11), pp.935~946 (2019), 대한약학회[DOI]
  55. Caldwell, S. H., "Mitochondrial abnormalities in non-alcoholic steatohepatitis", J. Hepatol, 31, pp.430~434 (1999)
  56. Perez-Carreras, M., "Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis", Hepatology, 38, pp.999~1007 (2003)
  57. Mantena, S. K., "Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol-and obesity-induced fatty liver diseases", Free Radic Biol. Med, 44, pp.1259~1272 (2008)
  58. Fromenty, B., "Mitochondrial alterations in fatty liver diseases", J. Hepatol, 78, pp.415~429 (2023)
  59. Li, X., "Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice", Br. J. Pharmacol, 177, pp.3591~3607 (2020)
  60. Ivankovic, D., "Mitochondrial and lysosomal biogenesis are activated following PINK1", parkin-mediated mitophagy, 2016, pp.136, 388~402
  61. Figueiredo-Pereira, C., "Carbon Monoxide Stimulates Both Mitophagy And Mitochondrial Biogenesis to Mediate Protection Against Oxidative Stress in Astrocytes", Mol Neurobiol, 60, pp.851~863 (2023)
  62. Kim, H. J., "Carbon monoxide-induced TFEB nuclear translocation enhances mitophagy", mitochondrial biogenesis in hepatocytes and ameliorates inflammatory liver injury, 2018, pp.9, 1060~
  63. Zhu, L., "Mechanism and regulation of mitophagy in nonalcoholic fatty liver disease(NAFLD) : A mini-review", Life Sci, 312, pp.121162~ (2023)

관련 논문AI추천

Transcriptional coordination of hepatic autophagy by nutrient-sensing nuclear receptor PPARα and FXR이재만대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2016 · 제21권 제4호MicroRNA regulation of AMPK in nonalcoholic fatty liver diseaseKemper Jongsook Kim, Sun Hao생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 Canagliflozin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism and Inhibiting Inflammation through Induction of AutophagyBin Wang, Dan Wei, Jianning Wang, Ting Xu, Wenxin Hu, Zhipeng Xu연세대학교의과대학 · Yonsei Medical Journal2022 · 제63권 제7호Fas apoptotic inhibitor molecule 2 mitigates metabolic dysfunction-associated fatty liver disease through autophagic CRTC2 degradationHuang Yongping, Hu Sha, Hu Yufeng, Li Dajun, Shi Hongjie, Wang Haitao, Yu Hong, Yu Yongjie, Zhang Peng, Zhang Tuo, Zhang Yu, Zhao Guang-Nian생화학분자생물학회 · Experimental and Molecular Medicine2025 · 제57권 Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis이유진, Baek Jung-Hwan, Chung Joon-Yong, Chun Kyung-Hee, Han Dai Hoon, Hwang Ilseon, Hwang Min-Seon, Im Seung-Soon, Jung Hye Ryeon, Kim Kyungeun, Kim Myung Sup, Lee Chan-ho, Lee Yong-ho생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 Downregulation of GNAI3 Promotes the Pathogenesis of Methionine/Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver DiseaseChangku Jia, Hanzhang Zhu, Jun Lu, Ke Ge거트앤리버 소화기연관학회협의회 · Gut and Liver2020 · 제14권 제4호

이 간행물의 다른 논문 (225건)

Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics김성영, Han Yeaeunpp. 1-12Grave-to-cradle: human embryonic lineage tracing from the postmortem bodyKu Eu Jeong, Choi Seock Hwan, Choi Yujin Angelina, Oh Ji Wonpp. 13-21Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesisKim Tae-Hee, Loe Adrian Kwan Ho, Zhu Lexinpp. 22-31TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cellsCha Hyuk-Jin, Kim Yun-Jeong, Go Young-Hyun, 정호창, Kwon Eun-Ji, Kim Seong-Min, Cheong Hyun Sub, Kim Wantae, Shin Hyoung Doo, Lee Haeseungpp. 32-42ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5Nam Hae Yun, 김성학, 김승후, 최경철, Park Seung-Ho, Song Ji-Hye, Jeong Ji-Hoon, Kim Hyunhee, Jeong Minseok, Kong Min-Jeong, Son Jihyun, Jeong Ji-Eunpp. 43-54
원문 보기